These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32557311)

  • 1. Utilizing Advanced Technologies to Augment Pharmacovigilance Systems: Challenges and Opportunities.
    Lewis DJ; McCallum JF
    Ther Innov Regul Sci; 2020 Jul; 54(4):888-899. PubMed ID: 32557311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automation Opportunities in Pharmacovigilance: An Industry Survey.
    Ghosh R; Kempf D; Pufko A; Barrios Martinez LF; Davis CM; Sethi S
    Pharmaceut Med; 2020 Feb; 34(1):7-18. PubMed ID: 32036574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validating Intelligent Automation Systems in Pharmacovigilance: Insights from Good Manufacturing Practices.
    Huysentruyt K; Kjoersvik O; Dobracki P; Savage E; Mishalov E; Cherry M; Leonard E; Taylor R; Patel B; Abatemarco D
    Drug Saf; 2021 Mar; 44(3):261-272. PubMed ID: 33523400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial intelligence in pharmacovigilance - Opportunities and challenges.
    Desai MK
    Perspect Clin Res; 2024; 15(3):116-121. PubMed ID: 39140015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacovigilance in Crisis: Drug Safety at a Crossroads.
    Price J
    Clin Ther; 2018 May; 40(5):790-797. PubMed ID: 29605513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial Intelligence Within Pharmacovigilance: A Means to Identify Cognitive Services and the Framework for Their Validation.
    Mockute R; Desai S; Perera S; Assuncao B; Danysz K; Tetarenko N; Gaddam D; Abatemarco D; Widdowson M; Beauchamp S; Cicirello S; Mingle E
    Pharmaceut Med; 2019 Apr; 33(2):109-120. PubMed ID: 31933254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a checklist for the assessment of pharmacovigilance guidelines in Southern Africa: a document review.
    Makhene NL; Steyn H; Vorster M; Lubbe MS; Burger JR
    Ther Adv Drug Saf; 2023; 14():20420986221143272. PubMed ID: 36713000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What place for intelligent automation and artificial intelligence to preserve and strengthen vigilance expertise in the face of increasing declarations?
    Pariente A; Micallef J; Lahouegue A; Molimard M; Auffret M; Chouchana L; Denis B; Faillie JL; Grandvuillemin A; Letinier L; Pierron E; Pons C; Pujade I; Rubino H; Salvo F
    Therapie; 2023; 78(1):131-143. PubMed ID: 36572627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Industry Perspective on Artificial Intelligence/Machine Learning in Pharmacovigilance.
    Kassekert R; Grabowski N; Lorenz D; Schaffer C; Kempf D; Roy P; Kjoersvik O; Saldana G; ElShal S
    Drug Saf; 2022 May; 45(5):439-448. PubMed ID: 35579809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Will the future of pharmacovigilance be more automated?
    Salvo F; Micallef J; Lahouegue A; Chouchana L; Létinier L; Faillie JL; Pariente A
    Expert Opin Drug Saf; 2023; 22(7):541-548. PubMed ID: 37435796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacovigilance in Israel - tools, processes, and actions.
    Schwartzberg E; Berkovitch M; Dil Nahlieli D; Nathan J; Gorelik E
    Isr J Health Policy Res; 2017 Aug; 6(1):29. PubMed ID: 28760141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Training Augmented Intelligent Capabilities for Pharmacovigilance: Applying Deep-learning Approaches to Individual Case Safety Report Processing.
    Abatemarco D; Perera S; Bao SH; Desai S; Assuncao B; Tetarenko N; Danysz K; Mockute R; Widdowson M; Fornarotto N; Beauchamp S; Cicirello S; Mingle E
    Pharmaceut Med; 2018; 32(6):391-401. PubMed ID: 30546259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Artificial Intelligence" for Pharmacovigilance: Ready for Prime Time?
    Ball R; Dal Pan G
    Drug Saf; 2022 May; 45(5):429-438. PubMed ID: 35579808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
    Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
    J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse Drug Reaction Case Safety Practices in Large Biopharmaceutical Organizations from 2007 to 2017: An Industry Survey.
    Stergiopoulos S; Fehrle M; Caubel P; Tan L; Jebson L
    Pharmaceut Med; 2019 Dec; 33(6):499-510. PubMed ID: 31933240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial Intelligence, Real-World Automation and the Safety of Medicines.
    Bate A; Hobbiger SF
    Drug Saf; 2021 Feb; 44(2):125-132. PubMed ID: 33026641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why Are We Still Creating Individual Case Safety Reports?
    Streefland MB
    Clin Ther; 2018 Dec; 40(12):1973-1980. PubMed ID: 30420290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strengthening the Pharmacovigilance System in Mexico: Implementation of VigiFlow and VigiLyze, as ICSR and Signal Detection Management Systems.
    Rayón-Ramírez G; Alvarado-López S; Camacho-Sandoval R; Loera MJ; Svarch AE; Alcocer-Varela J
    Pharmaceut Med; 2023 Nov; 37(6):425-437. PubMed ID: 37804414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacovigilance: An Overview.
    Beninger P
    Clin Ther; 2018 Dec; 40(12):1991-2004. PubMed ID: 30126707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacovigilance and the digital world in Italy: presentation of the results of a national survey.
    Stagi L; Bocchi I; Bianco S; Sirizzotti G; Bernardini D; Calderazzo V; Pirisino G; Grisoni I; Romano S
    Ther Adv Drug Saf; 2021; 12():2042098620985991. PubMed ID: 33623659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.